MedTrace Logo

The CHILD Cohort COVID-19 Add-On Study

NCT05234359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5385

Last updated 2023-05-26

No results posted yet for this study

Summary

The objective of this study is to determine the prevalence and transmission of SARS-CoV-2 infection among Canadian children and parents in the CHILD cohort, identify predictors of infection susceptibility and severity, and understand the health and psychosocial impacts of the COVID-19 pandemic on CHILD families.

Conditions

  • SARS-CoV Infection
  • Covid19

Interventions

DIAGNOSTIC_TEST

Serology Testing

A simple home sampling kit containing volumetric absorption microsampling devices (Mitra(R) cartidge device, Neoteryx LLC) will be used by the participants to collect a finger stick blood sample (10 ul; a few drops). Kits will be delivered to participants' homes and returned by mail. An instructional video will be provided.

DIAGNOSTIC_TEST

Stool sample

Stool samples collected for genetic, microbial and viral analysis.

Sponsors & Collaborators

  • Research Manitoba

    collaborator OTHER

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Meghan Azad, PhD · University of Manitoba

  • Padmaja Subbarao, MD · University of Toronto

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2022-04-30
Completion
2022-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05234359 on ClinicalTrials.gov